Brain and Cognition Discovery Foundation
Dr. Roger McIntyre: Mood Disorders and Metabolic-Inflammatory Comorbidity
updated
Watch Dr. Roger McIntyre, the Chairman & Executive Director of the Brain and Cognition Discovery Foundation, and Susie Goulding, the Founder of COVID Long Haulers Canada, as they discuss current research developments regarding long COVID and a possible treatment opportunity for long haulers!
Interested in more Long COVID research, events, and our clinical trial?
Connect with us on all of our Social Media or visit our Website!
Visit: bcdfoundation.ca
Twitter: twitter.com/BCDFoundation
Facebook: facebook.com/BrainCDF
Instagram: instagram.com/accounts/login/?next=%2Fbcdfoundation%2F
These cognitive difficulties are one symptom of ‘Long COVID’, which is a syndrome composed of multiple persistent symptoms including, but not limited to, difficulty breathing, lack of smell or taste, headache, and muscle or joint pains.
Watch our very own Dr. Roger McIntyre, the Chairman & Executive Director of the Brain and Cognition Discovery Foundation, as he explains more about Long COVID and how our clinical trial can help those suffering from Long COVID!
Interested in more Long COVID research, events, and our clinical trial?
Connect with us on all of our Social Media or visit our Website!
Visit: bcdfoundation.ca
Twitter: twitter.com/BCDFoundation
Facebook: facebook.com/BrainCDF
Instagram: instagram.com/accounts/login/?next=/bcdfoundation
Interested in more Long COVID research, events, and our clinical trial?
Connect with us on all of our Social Media or visit our website!
Visit: bcdfoundation.ca
Twitter: twitter.com/BCDFoundation
Facebook: facebook.com/BrainCDF
Instagram: instagram.com/accounts/login/?next=/bcdfoundation
Interested in more Long COVID research, events, and our clinical trial?
Connect with us on all of our Social Media or visit our website!
Visit: bcdfoundation.ca
Twitter: twitter.com/BCDFoundation
Facebook: facebook.com/BrainCDF
Instagram: instagram.com/accounts/login/?next=/bcdfoundation
Interested in more Long COVID research, events, and our clinical trial?
Connect with us on all of our Social Media or visit our website!
Visit: bcdfoundation.ca
Twitter: twitter.com/BCDFoundation
Facebook: facebook.com/BrainCDF
Instagram: instagram.com/accounts/login/?next=/bcdfoundation
Our very own Chairman & Executive Director of the Brain and Cognition Discovery Foundation, Dr. Roger McIntyre, and the Founder of COVID Long Haulers Canada, Susie Goulding, discussed long-lasting post-COVID symptoms, current research developments in Long COVID, and our clinical trial!
Interested in more Long COVID research, events, and our clinical trial?
Connect with us on all of our Social Media or visit our website!
Visit: bcdfoundation.ca
Twitter: twitter.com/BCDFoundation
Facebook: facebook.com/BrainCDF
Instagram: instagram.com/accounts/login/?next=/bcdfoundation
Event: The Syndemic of Mood Disorders, Medical Comorbidity and Sleep Disturbance: Navigating Assessment and Treatment Amidst the COVID-19 Pandemic
Date: May 20, 2021
Speaker: Dr. Roger McIntyre, FRCPC
Professor
Psychiatry & Pharmacology
University of Toronto
Head, MDPU, UHN
Executive Director, BCDF
Check out our website for more www.bcdfoundation.ca
Event: The Syndemic of Mood Disorders, Medical Comorbidity and Sleep Disturbance: Navigating Assessment and Treatment Amidst the COVID-19 Pandemic
Date: May 20, 2021
Speaker: Dr. Atul Khullar, MD MSc FRCPC DABPN
Fellow, American Academy of Sleep Medicine
Diplomate, American Board of Obesity Medicine
Medical Director, Northern Alberta Sleep Clinic
Associate Clinical Professor, University of Alberta
Check out our website for more www.bcdfoundation.ca
Event: The Syndemic of Mood Disorders, Medical Comorbidity and Sleep Disturbance: Navigating Assessment and Treatment Amidst the COVID-19 Pandemic
Date: May 20, 2021
Speaker: Dr. Marianna Golts, FRCPC
Assistant Professor
University of Toronto
Adult Psychiatry and Health Systems
Mount Sinai Hospital
Check out our website for more www.bcdfoundation.ca
Event: The Syndemic of Mood Disorders, Medical Comorbidity and Sleep Disturbance: Navigating Assessment and Treatment Amidst the COVID-19 Pandemic
Date: May 20, 2021
Speaker: Dr. Joshua D. Rosenblat, MD, MSc, FRCPC
Assistant Professor, Department of Psychiatry
University of Toronto
Staff Psychiatrist, MDPU
Medical Director, CRTCE
Co-founder & Research Director, 1907 Research
Check out our website for more www.bcdfoundation.ca
Event: The Syndemic of Mood Disorders, Medical Comorbidity and Sleep Disturbance: Navigating Assessment and Treatment Amidst the COVID-19 Pandemic
Date: May 20, 2021
Speaker: Dr. Roger McIntyre, FRCPC
Professor
Psychiatry & Pharmacology
University of Toronto
Head, MDPU, UHN
Executive Director, BCDF
Check out our website for more www.bcdfoundation.ca
Event: The Syndemic of Mood Disorders, Medical Comorbidity and Sleep Disturbance: Navigating Assessment and Treatment Amidst the COVID-19 Pandemic
Date: May 20, 2021
Speaker: Dr. Roger McIntyre, FRCPC
Professor
Psychiatry & Pharmacology
University of Toronto
Head, MDPU, UHN
Executive Director, BCDF
Check out our website for more www.bcdfoundation.ca
Event: The Syndemic of Mood Disorders, Medical Comorbidity and Sleep Disturbance: Navigating Assessment and Treatment Amidst the COVID-19 Pandemic
Date: May 20, 2021
Speaker: Dr. Atul Khullar, MD MSc FRCPC DABPN
Fellow, American Academy of Sleep Medicine
Diplomate, American Board of Obesity Medicine
Medical Director, Northern Alberta Sleep Clinic
Associate Clinical Professor, University of Alberta
Check out our website for more www.bcdfoundation.ca
Event: The Syndemic of Mood Disorders, Medical Comorbidity and Sleep Disturbance: Navigating Assessment and Treatment Amidst the COVID-19 Pandemic
Date: May 20, 2021
Speaker: Dr. Roger McIntyre, FRCPC
Professor
Psychiatry & Pharmacology
University of Toronto
Head, MDPU, UHN
Executive Director, BCDF
Check out our website for more www.bcdfoundation.ca
Event: The Syndemic of Mood Disorders, Medical Comorbidity and Sleep Disturbance: Navigating Assessment and Treatment Amidst the COVID-19 Pandemic
Date: May 20, 2021
Speaker: Dr. Joshua D. Rosenblat, MD, MSc, FRCPC
Assistant Professor, Department of Psychiatry
University of Toronto
Staff Psychiatrist, MDPU
Medical Director, CRTCE
Co -founder & Research Director, 1907 Research
Check out our website for more www.bcdfoundation.ca
Event: The Syndemic of Mood Disorders, Medical Comorbidity and Sleep Disturbance: Navigating Assessment and Treatment Amidst the COVID-19 Pandemic
Date: May 20, 2021
Speaker: Dr. Marianna Golts, FRCPC
Assistant Professor
University of Toronto
Adult Psychiatry and Health Systems
Mount Sinai Hospital
Check out our website for more www.bcdfoundation.ca
Event: Mood Disorders, ADHD and Obesity: Converging Neuroscience, Clinical Overlap and Novel Treatments
Date: October 24th, 2020
Speaker: Dr. Andrew Cutler
Assistant Professor, Psychiatry, University of Florida
Chief Medical Officer, Florida Clinical Research Center
Check out our website for more www.bcdfoundation.ca
Event: Mood Disorders, ADHD and Obesity: Converging Neuroscience, Clinical Overlap and Novel Treatments
Date: October 24th, 2020
Speaker: Josh Rosenblat, MD, FRCPC
Assistant Professor, University of Toronto
Staff Psychiatrist, MDPU
Medical Director, CRTCE
Research Director, 1907 Research
Check out our website for more www.bcdfoundation.ca
Date: October 24th, 2020
Check out our website for more www.bcdfoundation.ca
Mood Disorders
Event: Mood Disorders, ADHD and Obesity: Converging Neuroscience, Clinical Overlap and Novel Treatments
Date: October 24th, 2020
Speaker: Roger McIntyre, MD, FRCPC
Professor of Psychiatry and Pharmacology, University of Toronto
Executive Director, BCDF, Toronto, Ontario
Check out our website for more www.bcdfoundation.ca
Event Title: Mood Disorders and Metabolic-Inflammatory Comorbidity. What Does the Clinician Need to Know?
Event Date: February 24 2016
Event Location: Toronto, Ontario
Speaker:
Roger McIntyre, MD, FRCPC.
Professor of Psychiatry and Pharmacology
Executive Director, BCDF
Head, Mood Disorders Psychopharmacology Unit
University of Toronto
Topic:
Introduction from the Chair of the Brain and Cognition Discovery Foundation.
The Spectrum of Mood Disorders: New Perspectives on Diagnosis and Management.
Talk: 1 of 5
Event: Do ADHD and Depression Mediate Risk of Obesity and Diabetes or Vice Versa? Perspectives on Bidirectional Associations.
Fourth Annual Brain and Cognition Discovery Foundation Medical Conference
Date: February 9, 2019
Speaker: Thomas L. Schwartz, MD
Professor of Psychiatry & Behavioral Sciences
SUNY Upstate Medical University, Syracuse, NY
Check out our website for more www.bcdfoundation.ca
Event: Do ADHD and Depression Mediate Risk of Obesity and Diabetes or Vice Versa? Perspectives on Bidirectional Associations.
Fourth Annual Brain and Cognition Discovery Foundation Medical Conference
Date: February 9, 2019
Speaker: Harpreet Baja, MD, MPH, ECNU, FACE
Endocrinologist and Epidemiologist, LMC Diabetes & Endocrinology, Brampton, ON
Research Associate, Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto
Co-Chair, Marketing & Communication, Diabetes Canada National Professional Section
Columnist and blogger, www.medscape.com
Founder, “STOP Diabetes” Foundation Inc.
Check out our website for more www.bcdfoundation.ca
Event: Do ADHD and Depression Mediate Risk of Obesity and Diabetes or Vice Versa? Perspectives on Bidirectional Associations.
Fourth Annual Brain and Cognition Discovery Foundation Medical Conference
Date: February 9, 2019
Speaker: Roger McIntyre, MD, FRCPC
Professor of Psychiatry and Pharmacology, University of Toronto
Executive Director, BCDF, Toronto, Ontario
Check out our website for more www.bcdfoundation.ca
Event: Do ADHD and Depression Mediate Risk of Obesity and Diabetes or Vice Versa? Perspectives on Bidirectional Associations.
Fourth Annual Brain and Cognition Discovery Foundation Medical Conference
Date: February 9, 2019
Speaker: Roger McIntyre, MD, FRCPC
Professor of Psychiatry and Pharmacology, University of Toronto
Executive Director, BCDF, Toronto, Ontario
Check out our website for more www.bcdfoundation.ca
Event Date: May 12 2018
Event Location: Mississauga, Ontario
Speaker:
Roger McIntyre, MD, FRCPC.
Professor of Psychiatry and Pharmacology
Executive Director, BCDF
Head, Mood Disorders Psychopharmacology Unit
University of Toronto
Topic:
Human brain capital; Convergence of depression, ADHD and diabetes
Talk 1 of 4
Event Date: May 12 2018
Event Location: Mississauga, Ontario
Speaker:
Roger McIntyre, MD, FRCPC.
Professor of Psychiatry and Pharmacology
Executive Director, BCDF
Head, Mood Disorders Psychopharmacology Unit
University of Toronto
Topic:
Ketamine and Glutamatergic Treatment as Rapid Onset Treatments in Depression; Scientific Rationale and Clinical Application
Check out the Canadian Rapid Treatment Center of Excellence
crtce.com
Talk 4 of 4
Event Date: May 12 2018
Event Location: Mississauga, Ontario
Speaker:
Harpreet Singh Bajaj, MD, MPH, ECNU, FACE
Endocrinologist and Epidemiologist, LMC Diabetes & Endocrinology, Brampton, ON
Research Associate, Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto
Co-Chair, Marketing & Communication, Diabetes Canada National Professional Section
Columnist and blogger, www.medscape.com
Founder, “STOP Diabetes” Foundation Inc.
Topic:
The Impact of Diabetes and its Treatments on Mood and Cognition
Talk 3 of 4
Event Date: May 12 2018
Event Location: Mississauga, Ontario
Speaker:
David W. Goodman, MD
Assistant Professor of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine
Director of the Adult Attention Deficit Disorder Center of Maryland in Lutherville
Director of Suburban Psychiatric Associates, LLC
Topic:
ADHD and Bipolar Disorder in Adults
Talk: 2 of 4
Metabolic Considerations in Mood Disorders
Course Title: Clinical Considerations and Patient Centricity in the Management of Bipolar Disorder
Speaker:
Roger McIntyre, MD, FRCPC
Understanding the Diagnostic and Treatment Implications of DSM-5 Mood Disorders with Mixed Features
Course Title: Clinical Considerations and Patient Centricity in the Management of Bipolar Disorder
Speaker:
Joseph F. Goldberg, MD
CANMAT Bipolar Disorder Guidelines Update
Course Title: Clinical Considerations and Patient Centricity in the Management of Bipolar Disorder
Speaker:
Lakshmi Yatham, MBBS, FRCPC, MRCPsych(UK)
Session 6: Metabolism and Mood Disorders: Implications for Mechanisms and Treatment
Speaker:
Roger McIntyre, MD, FRCPC.
Professor of Psychiatry and Pharmacology
Executive Director, BCDF
Head, Mood Disorders Psychopharmacology Unit
University of Toronto
Check out more on our website: www.bcdfoundation.ca
Session 5: Redefining Treatment Goals in Major Depressive Disorder: Cognition as SIFI
Speaker:
Roger McIntyre, MD, FRCPC.
Professor of Psychiatry and Pharmacology
Executive Director, BCDF
Head, Mood Disorders Psychopharmacology Unit
University of Toronto
Check out more on our website: www.bcdfoundation.ca
Session 4: Comorbidity in Mood Disorders
Speaker:
Roger McIntyre, MD, FRCPC.
Professor of Psychiatry and Pharmacology
Executive Director, BCDF
Head, Mood Disorders Psychopharmacology Unit
University of Toronto
Check out more on our website: www.bcdfoundation.ca
Session 3: Pharmacological Treatments of Mood Disorders
Speaker:
Roger McIntyre, MD, FRCPC.
Professor of Psychiatry and Pharmacology
Executive Director, BCDF
Head, Mood Disorders Psychopharmacology Unit
University of Toronto
Check out more on our website: www.bcdfoundation.ca
Session 2: Neurobiology of Major Depressive Disorder and Bipolar Disorder
Speaker:
Roger McIntyre, MD, FRCPC.
Professor of Psychiatry and Pharmacology
Executive Director, BCDF
Head, Mood Disorders Psychopharmacology Unit
University of Toronto
Check out more on our website: www.bcdfoundation.ca
Session 1: Phenomenology of Major Depressive Disorder and Bipolar Disorder: From DSM-I to RDoC
Speaker:
Roger McIntyre, MD, FRCPC.
Professor of Psychiatry and Pharmacology
Executive Director, BCDF
Head, Mood Disorders Psychopharmacology Unit
University of Toronto
Check out more on our website: www.bcdfoundation.ca
Speaker:
Nassir Ghaemi, MD, MPH
Director, Mood Disorders Program
Tufts Medical Centre
Topic:
Historical and Conceptual Overview of Bipolar Disorder
Speakers:
Nassir Charmi, MD, MPH
Mark A. Frye, MD
Roger S. McIntyre, MD, FRCPC
Speaker:
Mark A. Frye, MD
Director, Depression Centre
Mayo Clinic
Topic:
Biomarkers for Bipolar Disorder -- Relevance to Clinical Practice
Speaker:
Roger McIntyre, MD, FRCPC.
Professor of Psychiatry and Pharmacology
Executive Director, BCDF
Head, Mood Disorders Psychopharmacology Unit
University Health Network
Topic:
Approaches to Management of Treatment of Bipolar Disorder Spectrum
Speaker:
John Harrison, BSc (Hons), PhD, CSci, CPsychol, AFBPsS
Associate Professor, Alzheimer's Centre, VUmc, Amsterdam
Honorary Professor, West London Mental Health Trust, UK
Consultant Psychologist, Metis Cognition Ltd., Kilmington, UK
Topic:
Measuring Cognition in Depression
Talk: 4 of 5
Check out more on our website: www.bcdfoundation.ca
Speaker:
Larry Culpepper, MD, MPH
Professor of Family Medicine, Boston University
Topic:
Depression Related Cognitive Dysfunction in Primary Care
Talk: 5 of 5
Check out more on our website: www.bcdfoundation.ca
Speaker:
Bernhard Baune, PhD, MD, MPH, FRANZCP
Professor and Chair of Psychiatry
Head, Discipline of Psychiatry
University of Adelaide
Topic:
Causes of Cognitive Dysfunction in Depression
Talk: 2 of 5
Check out more on our website: www.bcdfoundation.ca
Speaker:
John Harrison, BSc (Hons), PhD, CSci, CPsychol, AFBPsS
Associate Professor, Alzheimer's Centre, VUmc, Amsterdam
Honorary Professor, West London Mental Health Trust, UK
Consultant Psychologist, Metis Cognition Ltd., Kilmington, UK
Topic:
Measuring Cognition in Depression
Talk: 4 of 5
Check out more on our website: www.bcdfoundation.ca
Speaker:
Catherine J. Harmer, DPhil, MA, DipLATHE
Professor of Cognitive Neuroscience,
Department of Psychiatry,
Oxford University, Oxford
Topic:
'Hot' and 'Cold' Cognitive Impairment in Depression
Talk: 3 of 5
Check out more on our website: www.bcdfoundation.ca